Paul Fanikos, RPH, MPA/HA
Paul is the Executive Director at Alosa Health where he is responsible for providing leadership and oversight for the organization’s programs and services that focus on the development of evidence-based clinical practice guidelines, clinical outreach and education to providers and health systems to insure high-quality care for managing chronic conditions. Paul has more than 25 years experience directing disease and pharmaceutical educational programs that are focused on improving patient outcomes, containing costs, and optimizing customer satisfaction levels. Paul has held leadership roles with the countries largest pharmacy providers and pharmaceutical companies developing innovative solutions to challenges that impact healthcare practitioners, health systems, extended care facilities as well as homecare programs across the country. Paul received his pharmacy degree from Massachusetts College of Pharmacy and his Masters degree from Suffolk University.
Ellen Dancel, PharmD, MPH
Ellen is the Director of Clinical Materials Development at Alosa Health. Ellen was a pharmacist at the Massachusetts General Hospital for ten years prior to joining Alosa Health, serving in various leadership roles. She received her MPH in epidemiology from Boston University where she worked on a project looking for potential economic efficiencies in the global donor-funded antiretroviral market. As Director of Clinical Materials Development, she leads the development of evidence-based, academic materials, in partnership with clinical experts, and oversees the production of clinical content from concept to completion.
Jerry Avorn, MD
Dr. Avorn is Physician Advisor at Alosa Health. He is a graduate of Columbia College and Harvard Medical School; he completed his training in primary care internal medicine within the Harvard medical system. Dr. Avorn pioneered the concept of academic detailing in the 1980s, with the creation, deployment, and evaluation of the first such program. After testing it in a randomized trial in four state Medicaid programs, he went on to study the approach in nursing homes and demonstrated it significantly reduced overuse of antipsychotic drugs and improved the cognitive function of overmedicated patients. Both papers written on these trials were published in The New England Journal of Medicine. Dr. Avorn practiced internal medicine for over 30 years in ambulatory and in-hospital settings and helped to establish the program in geriatric medicine at Harvard. He is an expert in geriatric medication use, the study of adverse drug effects (particularly in patients with chronic disease), and medication cost-effectiveness analysis, and is the author of chapters on these subjects in the main textbooks in each field, as well being the author or co-author of over 400 papers in the medical literature. Dr. Avorn is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham & Women’s Hospital in Boston, one of the main Harvard teaching hospitals. In 2004 he participated in the founding of the Alosa Health, a non-profit organization dedicated to providing doctors with non-commercial education about medications. He was a co-author of the Institute of Medicine report on the development of trustworthy clinical guidelines, and the author of Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, published by Knopf and now in its 11th printing.
Niteesh Choudhry, MD, PhD
Dr. Choudhry is Physician Advisor at Alosa Health. He is a Professor at Harvard Medical School and Executive Director of the Center for Healthcare Delivery Sciences (www.c4hds.org) at Brigham and Women’s Hospital, where he also Associate Physician in the Division of Pharmacoepidemiology and Pharmacoeconomics and a practicing Hospitalist. Much of Dr. Choudhry’s work has dealt with design and evaluation of novel strategies to overcome barriers to the broader use of evidence-based therapies. His work employs many research methods including large pragmatic randomized trials, predictive analytics, and cost-effectiveness modeling and is funded by a wide variety of sources including the NIH, non-profit foundations, and health insurers. Dr. Choudhry attended McGill University, received his MD and completed his residency training in Internal Medicine at the University of Toronto and then served as Chief Medical Resident for the Toronto General and Toronto Western Hospitals. He earned his PhD in Health Policy from Harvard University. He has published over 200 scientific papers in leading medical and policy journals and the quality of his work has been recognized by many national and international organizations. Dr. Choudhry practices inpatient general internal/hospital medicine and has won numerous awards for teaching excellence and mentorship including the George W. Thorn and the Jean Jackson Awards.
Michael Fischer, MD, MS
Dr. Fischer is Physician Advisor at Alosa Health. He did his undergraduate work at Harvard College and attended Yale Medical School. At Brigham & Women’s Hospital, Dr. Fischer completed a residency in primary care medicine and has been practicing primary care since 2000. He received an MS degree in Clinical Effectiveness from the Harvard School of Public Health and is currently an Associate Professor of Medicine at Harvard Medical School. He is a widely published health services researcher studying the effects of reimbursement policies and other interventions on influencing physician prescribing and patient outcomes. For several years he headed the physician medication education program at BWH and has worked closely with Drs. Avorn and Choudhry on the Alosa Health programs of academic detailing since their inception in 2005. In this role, he has helped lead the creation of prescriber education materials and taken a central role in training academic detailers for several public sector programs. He is the Principal Investigator of the AHRQ-supported National Resource Center on Academic Detailing, which supports the creation and improvement of academic detailing programs throughout the country.
Jing Luo, MD, MPH
Dr. Luo is a Physician Advisor at Alosa Health. He is a graduate of Duke University and the University of Illinois at Chicago College of Medicine. He completed his residency in primary care internal medicine at Yale-New Haven Hospital and fellowship in general internal medicine at the Brigham and Women’s Hospital. He received his MPH in clinical effectiveness at the Harvard T.H. Chan School of Public Health, is an Instructor of Medicine at Harvard Medical School and a faculty member of the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital. He supports the production of clinical materials and is one of the primary clinical consultants.
Cheryl Bartlett, RN
Cheryl is a Health Policy Consultant for Alosa Health. Previously, Cheryl served as Commissioner of the Massachusetts Department of Public Health where she was recognized for leading the department’s groundbreaking work in several areas including; chairing the inaugural Prevention and Wellness Trust Fund Advisory Board, chair of the Statewide Comprehensive Cancer Advisory Board, chair for the Interagency Council on Substance Abuse Prevention and Chair of the Sexual Assault Nurse Examiner Program. Under her leadership, Massachusetts was the first state in the nation to declare a public health emergency related to overdose deaths from opioids and passed regulations to insure universal access to nasal naloxone for overdose prevention. Ms. Bartlett has extensive experience as a registered nurse and hospital administrator implementing health systems change based on quality assessment and improvement practices. She currently serves as Co-Chair of the Cape’s Regional Substance Abuse Council and on the Boards for Learn to Cope and the Massachusetts Organization for Addiction Recovery.
Rebecca Edelberg, MPH
Rebecca is the Program Coordinator at Alosa Health. She has an undergraduate degree from Tufts University and a Masters in Public Health from Boston University with concentrations in Epidemiology and Health Policy. Rebecca previously worked at Boston Medical Center implementing a clinical trial in the adolescent outpatient clinic. She also has several years of experience working as a consultant in the electronic medical records (EMR) industry, where she engaged in Academic Detailing style one-on-one clinician education.
Irina is the Finance Coordinator at Alosa Health. She is administering the flow of revenue and expenses, monthly reconciliations, financial reporting, and participates in the audit and budgeting processes. Irina has been working in non-profit accounting for eleven years, has a BS in Mathematics from the University of Bucharest, Romania, and currently pursuing a degree in Finance and Accounting Management at Northeastern University. She enjoys mathematical challenges and outdoor activities in the beautiful Boston area.
Corinna is the Office Administrator at Alosa Health. She graduated from Bates College with a BA in Cultural Musicology. After graduation, she moved back to her native Washington, DC where she got a head start in office administration and operations at a consulting firm in Georgetown. Corinna moved to Boston in early 2016 and started at Alosa Health in April 2016. She handles HR processes, IT needs, assists with financial procedures and manages other daily office procedures.